Skip to main content
Have a personal or library account? Click to login
Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy Cover

Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Radiology and Oncology
Volume 52 (2018): Issue 3 (September 2018)
By: Martina Vrankar and  Karmen Stanic  
Open Access
|Feb 2018
Metrics

Metrics

DOI: https://doi.org/10.2478/raon-2018-0009 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 281 - 288
Submitted on: Nov 22, 2017
Accepted on: Nov 30, 2017
Published on: Feb 21, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
locally advanced NSCLC,
survival,
immunotherapy,
PD-L1 expression,
chemoradiotherapy
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2018 Martina Vrankar, Karmen Stanic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 52 (2018): Issue 3 (September 2018)
Previous article
Next article